Clinical utility of polygenic risk scores in cardiovascular disorders

Heribert Schunkert1, Ling Li1, Teresa Trenkwalder1

  • 1TUM University Hospital Department of Cardiology Lazarettstr. 36 80636 Munich Germany.

Insights

Polygenic risk scores (PRS) can improve cardiovascular disease (CVD) risk prediction by assessing inherited susceptibility. This review explores PRS utility, construction, and clinical applications for major CVDs, identifying knowledge gaps for implementation.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Preventive Cardiology

Background:

  • Cardiovascular diseases (CVD) pose significant health risks, necessitating enhanced prediction and prevention.
  • Current clinical risk scores can be augmented by genetic information.
  • Polygenic risk scores (PRS) offer a way to quantify inherited susceptibility to diseases.

Purpose of the Study:

  • To review the current understanding and application of PRS in cardiovascular disease.
  • To discuss methodologies for PRS construction and clinical utility across various CVDs.
  • To identify challenges and knowledge gaps hindering PRS clinical implementation.

Main Methods:

  • Literature review of studies on PRS in cardiovascular disease.
  • Discussion of PRS construction methodologies.
  • Analysis of clinical scenarios and potential applications of PRS for major CVDs.

Main Results:

  • PRS can enhance risk stratification beyond traditional factors for conditions like coronary artery disease, aortic aneurysms, cardiomyopathies, atrial fibrillation, and hypertension.
  • The utility of PRS varies, serving as both a diagnostic tool and a research instrument.
  • Methodological strategies for PRS construction are evolving.

Conclusions:

  • PRS holds significant potential to personalize cardiovascular disease prevention and improve risk prediction.
  • Further research is needed to address knowledge gaps and facilitate widespread clinical implementation of PRS.
  • PRS can provide insights into the complex etiologies of cardiovascular diseases.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...